Amgen 386 for Recurrent Glioblastoma

Clinical trial NCT01290263 · COMPLETED

Trial details

NCT number: NCT01290263
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2010-12-01
Primary completion: 2015-07-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.